MRI and Biomarkers in Prostate Cancer (Multi-IMPROD)
MULTI-IMPROD clinical trial ( ClinicalTrials.gov Identifier NCT02241122 )
is a mutli-institutional validation trial of IMPROD trial ( NCT01864135 ) using the same clinical trial set up,
MRI acquisition and reporting system as IMPROD trial.
Multi-IMPROD validated at 4 centers the use of high quality rapid 3 Tesla biparametric magnetic resonance imaging (bpMRI),
T2-weighted imaging and three separate diffusion-weighted imaging acquisitions,
combined with targeted biopsy (TB) for improving risk stratification of men with elevated prostate-specific antigen (PSA) before their first biopsy.